
Auteur K. ARASTEH
|
Documents disponibles écrits par cet auteur (8)

D. C. DES JARLAIS ; J. P. FEELEMYER ; S. N. MODI ; K. ARASTEH ; H. HAGAN | 2012
Dans Drug and Alcohol Dependence (Vol.124, n°1-2, July 2012) Article : PériodiqueObjective: There are multiple reasons why females who inject drugs may be more likely to become infected with HIV than males who inject drugs. Where this is the case, special HIV prevention programs for females would be needed. Design: Internat[...]
D. C. DES JARLAIS ; H. HAGAN ; K. ARASTEH ; C. McKNIGHT ; S. SEMAAN ; D. C. PERLMAN | 2011
Dans Drug and Alcohol Dependence (Vol.119, n°3, December 2011) Article : PériodiqueBACKGROUND: Preventing HCV infection among people who inject drugs is a difficult public health challenge. We examined the potential role of intranasal drug use in reducing HCV acquisition. METHODS: Subjects were recruited from IDUs entering t[...]
D. C. DES JARLAIS ; K. ARASTEH ; J. FEELEMYER ; C. McKNIGHT ; D. M. BARNES ; S. TROSS ; D. C. PERLMAN ; A. N. C. CAMPBELL ; H. L. F. COOPER ; H. HAGAN | 2016
Dans Journal of Substance Abuse Treatment (Vol.71, Decembre 2016) Article : PériodiqueObjectives: Transitioning from injecting to non-injecting routes of drug administration can provide important individual and community health benefits. We assessed characteristics of persons who had ceased injecting while continuing to use heroi[...]
D. C. DES JARLAIS ; K. ARASTEH ; S. SEMAAN ; E. WOOD | 2009
Dans Current Opinion in HIV and AIDS (Vol.4, n°4, 2009) Article : PériodiquePURPOSE OF REVIEW: To describe recent research done primarily during the past 12 months (i.e., primarily in 2008) on the epidemiology of HIV infection among injecting drug users (IDUs). RECENT FINDINGS: Major research developments include a gl[...]
D. C. DES JARLAIS ; PERLIS.T. ; K. ARASTEH ; TORIAN L. ; S. BEATRICE ; MILLIKEN J. ; MILDVAN D. ; YANCOVITZ S. ; S. FRIEDMAN | 2005
Dans American Journal of Public Health (Vol.95 n°8, 2005) Article : PériodiqueObjectives. We sought to estimate HIV incidence among injection drug users (IDUs) in New York City from 1990 to 2002 to assess the impact of an expansion of syringe exchange services. Syringe exchange increased greatly during this period, from 2[...]
D. C. DES JARLAIS ; T. KERR ; P. CARRIERI ; J. FEELEMYER ; K. ARASTEH | 2016
Dans AIDS (Vol.30, n°6, March 27, 2016) Article : PériodiqueAIDS among persons who inject drugs, first identified in December 1981, has become a global epidemic. Injecting drug use has been reported in 148 countries and HIV infection has been seen among persons who inject drugs in 61 countries. Many loca[...]
A. E. JORDAN ; D. C. DES JARLAIS ; K. ARASTEH ; C. McKNIGHT ; D. NASH ; D. C. PERLMAN | 2015
Dans Drug and Alcohol Dependence (Vol.152, July 2015) Article : PériodiqueBackground: Hepatitis C virus infection is a source of significant preventable morbidity and mortality among persons who inject drugs (PWID). We sought to assess trends in hepatitis C virus (HCV) infection among PWID from 2006 to 2013 in New Yor[...]Nouveauté
D. C. DES JARLAIS ; K. ARASTEH ; C. McKNIGHT ; J. FEELEMYER ; A. N. C. CAMPBELL ; S. TROSS ; H. L. F. COOPER ; H. HAGAN ; D. C. PERLMAN | 2017
Dans Addiction (Vol.112, n°2, February 2017) Article : PériodiqueBackground and aims: HIV has reached high prevalence in many non-injecting drug user (NIDU) populations. The aims of this study were to (1) examine the trend in HIV prevalence among non-injecting cocaine and heroin NIDUs in New York City, (2) id[...]